Overview
The assessment of a variety of factors, obtained from clinical examination, bio-humoral analysis, and cardiac imaging allow the prognostic stratification of patients with previous myocardial infarction (MI). 1, 2 In particular, adopting different imaging modalities, left ventricular (LV) systolic dysfunction, LV dilatation and remodelling, the severity and extent of regional wall motion abnormalities, and the extent of necrotic tissue have all been shown to be of prognostic relevance in patients with previous MI. 3 In particular, the dilatation of both LV end-diastolic volume (LVEDV) and LV end-systolic volume (LVESV) has been related to high incidence of cardiac death, where LVEDV was the only echocardiographic predictor of death in the BEST study.
tion of LV volumes, LV global and regional function, and scar tissue extent in a one-stop-shop modality. 5 At present, there are no open-access datasets in the CMR field, which provide the opportunity to approach cardiac research studies in an integrated, multidisciplinary, systematic and multicentric framework. Our group has worked for many years in the assessment of cardiac function and morphology by cardiac imaging. An institutional database, IMAGE, has been created to store the most important clinical and instrumental data obtained during hospitalization of patients, affected by cardiovascular disease, from different laboratories (ergometry, echocardiographic, nuclear medicine and hemodynamic). In this report, we present a dataset obtained from CMR in patients with previous MI. Part of these data has been referenced in a previously published study that considered a multiparametric approach for prognostic stratification in patients with previous MI. 6 
Methods
We studied 231 patients (64.3±10.9 years old) with previous MI referred to routine CMR from July 2001 to March 2007. Previous MI was documented by clinical records or by the presence of diagnostic Q-waves in a 12-lead ECG recording, and was older than 3 months in every patient. The inclusion criteria also included angiographically documented coronary stenosis reducing luminal diameter by at least 50 % in one major coronary artery and stable clinical conditions.
In every patient, CMR examination was done 6 months before or after a revascularization procedure. Patients were studied either as out-patient or during the hospitalization period. The clinical characteristics were collected before CMR examination. The study was approved by the local Ethics Committee; the investigation conformed to the principles outlined in the Declaration of Helsinki.
Cardiac Magnetic Resonance Data Acquisition
CMR was performed using a 1.5T whole body scanner (GE Medical Systems, Milwaukee, WI, USA). A 8-channel cardiac phased-array receiver surface coil was used for signal reception. A breath-hold steady-state free-precession ECGtriggered sequence was used to evaluate global LV function. In each patient, a set of contiguous short-axis views were acquired from the mitral plane to the apex and two long-axis views (one vertical and one horizontal) were acquired, with a minimum of 30 cine frames for each slice with the following parameters: slice thickness 8 mm, no gap, eight views per segment, NEX 1, field of view 40 cm, phase field of view 1, matrix 224 × 224, reconstruction matrix 256 × 256, flip angle 458, TR/TE 3.5/1.5, and bandwidth 125 KHz. Late gadolinium enhancement (LGE) images were obtained 8-10 min after bolus injection of gadolinium derivates (Omniscanw, Amersham, GE Medical System or Magnevistw, Shering).
Images were acquired in the same short-axis and long-axis slices as used for cine CMR. The fast Gradient Echo Inversion Recovery sequence was utilized with the following parameters: repetition time 4.2 ms, echo time minimum, flip angle 208, matrix 224 × 224, number of excitations 1.00, field of view 36 mm, slice thickness 8 mm, no inter-slice gap. The inversion time was optimized to null signal from the normal myocardium.
Cardiac Magnetic Resonance Data Analysis
To determine LV function, endocardial borders were manually drawn on all LV short-axis images by means of previously validated software (Massw, MEDIS, The Netherlands). The LV mass, LVESV, and LVEDV, normalized for the body mass index (mL/m2), were then calculated and the LVEF was derived. LV was divided into 17 segments including six basal, six middle, four distal segments, and the apex. 7 Wall motion of each segment was graded semi-quantitatively according to a fourpoint scale where 1 is normal, 2 is hypokinetic, 3 is akinetic, and 4 is dyskinetic. The score of the segments belonging to an LV wall was averaged to derive the wall motion score index (WMSI). The ratio mass/EDV was considered as an LV remodelling index. 8, 9 The global LGE extent was measured using a semiautomatic, software. 10 In each image, boundaries of contrast-enhanced areas were automatically traced (using a signal intensity cut-off of > 5 SD over the average of normal remote myocardium) and manually corrected when needed. The reproducibility of this method has been previously validated. 10 The transmural LGE extent was measured by standard techniques. 11 For each segment, the LGE transmural extent was expressed as percentage of total segment area and clustered as follows: 1-25; 26-50; 51-75; or >75%. Furthermore, LVEDV, WMSI, and LGE extent were then dichotomized according to their median values.
Follow-up Data Acquisition
A questionnaire compiled by a clinical physician during periodic ambulatory work up in our institute or telephone contact was used for follow-up acquisition of data. The length of follow-up was from 3 months to ~8 years. The events considered were cardiac death, and appropriate implantable cardiac defibrillator (ICD) shock. The cause of death was derived from medical records or death certificates. The definition of cardiac death required the documentation of significant arrhythmia or cardiac rest or death attributable to congestive heart failure or MI in the absence of any other precipitating factor. A complete interrogation of the ICD was performed by the referring physician in order to confirm the appropriateness of the shock.
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Data Records
The data in the accompanying spreadsheet is organised in the following columns:
A: It shows the ID of the subject.
B:
It shows the sex of the subjects (1= male; 0= female). 
C:
Validation
Using the CMR dataset described in this paper, we showed that a multiparametric CMR approach, including the measure of scar tissue extent, LV enddiastolic volume and regional wall motion abnormalities, together with age, fine-tunes risk stratification of patients with previous MI. In particular, when the WMSI is 1.7, the extent of scar tissue exceeds 12.7 % of the LV mass, and LV volume is .105 mL/m2, the survival free of cardiac death is lower than when two, one, or none of these factors are present.
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Use and Potential Reuse
The dataset described in this paper, or part of it, has been already used to assess the CMR role in patients with previous MI, specifically regarding the relationship between electrocardiographic signs of previous MI and LGE global extent and location, and prognosis. Recently, in patients with inferior and/or lateral MI, a prominent T wave in V2 with respect to V6 corresponded to a greater infarct extent in the lateral wall. 13 Further, the potential to assess transmural extent of MI with LGE technique allowed us to demonstrate that necrotic and viable myocardium coexistence within the same wall segments predicted occurrence of non-sustained ventricular tachycardia in patients with previous MI and without left ventricular dilatation.
14 CMR is considered the non-invasive and nonionizing gold standard imaging technique to assess both right and left ventricles. With this dataset, we showed that right ventricular dysfunction is an independent and incremental predictor of cardiac events in patients with previous MI. In these patients, right ventricular dysfunction does not nec-essarily mean right ventricular infarction scar, but likely reflects the effects of hemodynamic and biohumoral factors activated in patients with left ventricular dysfunction. 15 
Conclusion
In conclusion, the CMR and clinical dataset of patients with previous MI, attached in this paper, can be reused to assess the CMR role in the prognostic stratification of patients with previous MI in a large and multicentre study population. In addition, data sharing of clinical, bio-humoral, and imaging variables could allow generation of a multiparametric score to identify patients with higher risk of major cardiac events and to define targeted therapeutic interventions as implanted cardioverter defibrillator.
Data Files
The data described in this paper is presented in an openly accessible spreadsheet: "01305_Cardiac_ Magnetic_Resonance_Imaging.xls".
The file is available also in the Open Document Spreadsheet format.
